{"id":"https://openalex.org/W7133199784","doi":"https://doi.org/10.1158/1078-0432.31442881","title":"Supplemental Table 5 from Axicabtagene Ciloleucel in Combination with Atezolizumab in Patients with Refractory Diffuse Large B-Cell Lymphoma: The Phase 1/2 ZUMA-6 Trial","display_name":"Supplemental Table 5 from Axicabtagene Ciloleucel in Combination with Atezolizumab in Patients with Refractory Diffuse Large B-Cell Lymphoma: The Phase 1/2 ZUMA-6 Trial","publication_year":2026,"publication_date":"2026-03-02","ids":{"openalex":"https://openalex.org/W7133199784","doi":"https://doi.org/10.1158/1078-0432.31442881"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.31442881","doi":"https://doi.org/10.1158/1078-0432.31442881","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.31442881","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.31442881","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037526878","display_name":"Caron Alyce Jacobson","orcid":"https://orcid.org/0000-0002-0180-0654","observed_orcids":["https://orcid.org/0000-0002-0180-0654"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Caron A. Jacobson","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0180-0654","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021496101","display_name":"Jason R. Westin","orcid":"https://orcid.org/0000-0002-1824-2337","observed_orcids":["https://orcid.org/0000-0002-1824-2337"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jason R. Westin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1824-2337","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081926380","display_name":"David Bernard Miklos","orcid":"https://orcid.org/0000-0003-0717-4305","observed_orcids":["https://orcid.org/0000-0003-0717-4305"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David B. Miklos","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0717-4305","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030788778","display_name":"Alex Francisco Herrera","orcid":"https://orcid.org/0000-0002-9665-7415","observed_orcids":["https://orcid.org/0000-0002-9665-7415"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alex F. Herrera","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9665-7415","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008718116","display_name":"Jerome Ritz","orcid":"https://orcid.org/0000-0001-5526-4669","observed_orcids":["https://orcid.org/0000-0001-5526-4669"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jerome Ritz","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5526-4669","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058975989","display_name":"Scott J. Rodig","orcid":"https://orcid.org/0000-0003-1761-9769","observed_orcids":["https://orcid.org/0000-0003-1761-9769"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Scott Rodig","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1761-9769","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052568829","display_name":"Yohei Arihara","orcid":"https://orcid.org/0009-0001-7673-3724","observed_orcids":["https://orcid.org/0009-0001-7673-3724"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yohei Arihara","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0001-7673-3724","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027792817","display_name":"Subing Cao","orcid":"https://orcid.org/0000-0003-2416-5742","observed_orcids":["https://orcid.org/0000-0003-2416-5742"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Subing Cao","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2416-5742","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085588647","display_name":"Jennifer Sun","orcid":"https://orcid.org/0009-0008-8649-3817","observed_orcids":["https://orcid.org/0009-0008-8649-3817"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jennifer Sun","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0008-8649-3817","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041486255","display_name":"Daqin Mao","orcid":"https://orcid.org/0009-0007-2814-3969","observed_orcids":["https://orcid.org/0009-0007-2814-3969"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daqin Mao","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0007-2814-3969","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112461283","display_name":"Sabina Adhikary","orcid":"https://orcid.org/0009-0002-7578-6223","observed_orcids":["https://orcid.org/0009-0002-7578-6223"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sabina Adhikary","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0002-7578-6223","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5121975373","display_name":"Frank Neumann","orcid":"https://orcid.org/0009-0001-0995-1537","observed_orcids":["https://orcid.org/0009-0001-0995-1537"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Frank Neumann","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0001-0995-1537","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035796208","display_name":"Nikolay Grechko","orcid":"https://orcid.org/0009-0009-8090-9938","observed_orcids":["https://orcid.org/0009-0009-8090-9938"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nikolay Grechko","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0009-8090-9938","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5021394406","display_name":"Frederick Lundry Locke","orcid":"https://orcid.org/0000-0001-9063-6691","observed_orcids":["https://orcid.org/0000-0001-9063-6691"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Frederick L. Locke","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9063-6691","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9702000021934509,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9702000021934509,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.023900000378489494,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/axicabtagene-ciloleucel","display_name":"axicabtagene ciloleucel","score":0.9990000128746033},{"id":"https://openalex.org/keywords/atezolizumab","display_name":"atezolizumab","score":0.984000027179718},{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.9750000238418579},{"id":"https://openalex.org/keywords/refractory-lymphoma","display_name":"refractory lymphoma","score":0.984000027179718},{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.828000009059906},{"id":"https://openalex.org/keywords/serum-biomarkers","display_name":"serum biomarkers","score":0.8379999995231628},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.4339999854564667}],"concepts":[{"id":"https://openalex.org/C2775949291","wikidata":"https://www.wikidata.org/wiki/Q20707748","display_name":"Atezolizumab","level":5,"score":0.8877000212669373},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5658000111579895},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.48240000009536743},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.41830000281333923},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38499999046325684},{"id":"https://openalex.org/C10390740","wikidata":"https://www.wikidata.org/wiki/Q2282401","display_name":"Analyte","level":2,"score":0.38350000977516174},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.3824999928474426},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.36230000853538513},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.34540000557899475},{"id":"https://openalex.org/C45235069","wikidata":"https://www.wikidata.org/wiki/Q278425","display_name":"Table (database)","level":2,"score":0.3441999852657318},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.34150001406669617},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.33059999346733093},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3084999918937683}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.31442881","doi":"https://doi.org/10.1158/1078-0432.31442881","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.31442881","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.31442881","doi":"https://doi.org/10.1158/1078-0432.31442881","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.31442881","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2914767419","https://openalex.org/W4416187225","https://openalex.org/W3083435126","https://openalex.org/W7133244045","https://openalex.org/W4408810144","https://openalex.org/W4252586965","https://openalex.org/W4232771883","https://openalex.org/W2797193430","https://openalex.org/W4410251267","https://openalex.org/W4321607142"],"abstract_inverted_index":{"Serum":[0],"biomarker":[1],"analyte":[2],"measurements":[3]},"counts_by_year":[],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2026-03-03T00:00:00"}